LDL-Cholesterol Lowering With Atorvastatin, Rosuvastatin and Simvastatin: Results of a Retrospective Observational Study.

Puntos clave

• Atorvastatin and rosuvastatin showed greater LDL-cholesterol reduction than simvastatin, indicating better efficacy.
• The study found that combination therapy with ezetimibe significantly increased the likelihood of reaching LDL targets.
• This retrospective observational analysis provides insight into lipid management in primary care settings.
• Findings suggest that utilizing atorvastatin or rosuvastatin with ezetimibe may optimize cholesterol treatment.